Julie Lang

5PUBLICATIONS
43CO-AUTHORS
Molecular targetsCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 25, 2026
Nephrotoxicity of Immune Checkpoint Inhibitors in Mice with a Human Immune System.

|Oct 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.

Robert W Lentz, Julie Lang, Todd M Pitts

|Dec 03, 2024
Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival.

Fabian R Villagomez, Julie Lang, Daniel Nunez-Avellaneda

|Jan 31, 2024
Claudin-4 modulates autophagy via SLC1A5/LAT1 as a tolerance mechanism for genomic instability in ovarian cancer.

Fabian R Villagomez, Julie Lang, Patricia Webb

|Feb 10, 2019
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.

A Capasso, J Lang, T M Pitts

Pageof 1

Frequent Collaborators

2 joint publications

Fabian R Villagomez

2 joint publications

Elizabeth R Woodruff

2 joint publications

Benjamin G Bitler

1 joint publications

Margaret Neville